EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Obesity in Breast Cancer Pathogenesis

Ira Glassman iD, Nghia Le, Aamna Asif, Anabel Goulding, Cheldon Ann Alcantara, Annie Vu, Abraham Chorbajian, Mercedeh Mirhosseini, Manpreet Singh, Vishwanath Venketaraman iD

Cells · 14.08.2023 · 12 (16) · 2061

DOI: 10.3390/cells12162061 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 14.08.2023. Verfasst von Ira Glassman und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Research has shown that obesity increases the risk for type 2 diabetes mellitus (Type 2 DM) by promoting insulin resistance, increases serum estrogen levels by the upregulation of aromatase, and promotes the release of reactive oxygen species (ROS) by macrophages. Increased circulating glucose has been shown to activate mammalian target of rapamycin (mTOR), a significant signaling pathway in breast cancer pathogenesis. Estrogen plays an instrumental role in estrogen-receptor-positive breast cancers. The role of ROS in breast cancer warrants continued investigation, in relation to both pathogenesis and treatment of breast cancer. We aim to review the role of obesity in breast cancer pathogenesis and novel therapies mediating obesity-associated breast cancer development. We explore the association between body mass index (BMI) and breast cancer incidence and the mechanisms by which oxidative stress modulates breast cancer pathogenesis. We discuss the role of glutathione, a ubiquitous antioxidant, in breast cancer therapy. Lastly, we review breast cancer therapies targeting mTOR signaling, leptin signaling, blood sugar reduction, and novel immunotherapy targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2NeoplasmsHumansReactive Oxygen SpeciesObesityEstrogensTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

BMIbreast cancerdiabetes mellitusglutathioneleptinmTORobesity

Substanzen

Reactive Oxygen SpeciesEstrogensTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
  • Corona Regional Medical Center, Department of Emergency Medicine, Corona, CA 92882, USA.

ORCID-Profile: Ira Glassman, Vishwanath Venketaraman

Förderung

  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Glassman, I., Le, N., Asif, A., Goulding, A., Alcantara, C. A., Vu, A., Chorbajian, A., Mirhosseini, M., Singh, M., & Venketaraman, V. (2023). The Role of Obesity in Breast Cancer Pathogenesis. Cells, 12(16), 2061. https://doi.org/10.3390/cells12162061

Vancouver

Glassman I, Le N, Asif A, Goulding A, Alcantara CA, Vu A, et al. The Role of Obesity in Breast Cancer Pathogenesis. Cells. 2023;12(16):2061. doi:10.3390/cells12162061

BibTeX
@article{Glassman2023,
  author = {Glassman, Ira and Le, Nghia and Asif, Aamna and Goulding, Anabel and Alcantara, Cheldon Ann and Vu, Annie and Chorbajian, Abraham and Mirhosseini, Mercedeh and Singh, Manpreet and Venketaraman, Vishwanath},
  title = {The Role of Obesity in Breast Cancer Pathogenesis},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {16},
  pages = {2061},
  doi = {10.3390/cells12162061}
}
Kostenlos starten →